Branch Retinal Vein Occlusion

David Christian Chandra, MD., Eugeni Sumanti, MD

Department of Ophthalmology, Faculty of Medicine Sam Ratulangi University
Prof. Dr. R.D. Kandou General Hospital, Manado, North Sulawesi

Introduction
Retinal vein occlusion is the second most common retinal vascular disorder following
diabetic retinopathy and is often associated with vision loss. With comprehensive
management, we can encourage management of potential risk factors for retinal vein
occlusion.

Case Presentation
A seventy-year old man, referred to Kandou hospital with suspect hypertension retinopathy.
Main complaint is blurred vision left eye since 1 month ago. Patient felt no pain. Patient use
glasses since 20 years ago to help him reading. No history of smoking. No history of ocular
problems, any other medication and previous eye examination. His visual acuities were 6/9
right eye, and 6/60 left eye, intraocular pressure were 15.1 mmHg right eye, and 14.5 mmHg
left eye. Right eye was unremarkable. Posterior segment of the left eye revealed hemorrhage
on the supero-temporal quadrant. Patient was diagnosed with branch retinal vein occlusion of
left eye. Patient was referred to internist to regulate blood pressure and injection of
ranibizumab on the left eye performed 1 weeks later. 2 weeks after surgery, VA of Left eye is
6/30. Second injection is planned 1 months after the 1st injection

Discussion
BRVO is caused by thrombosis in retinal vein. There is no known certain ethiology until this
day. But there are some risk factor that affecting BRVO such as increased age, hypertension,
history of smoking, glaucoma and hypercoagulable conditions.

Conclusion
Figure 1 : Pre Injection Ranibizumab Fundus Figure 2 : Post Injection Ranibizumab
Injection of anti VEGF is still the most rationale treatment for retinal vein occlusion these
and OCT of the left eye Fundus and OCT of the left eye
days. Focal laser treatment can be added to prevent neovascularitation.

References :
1.AAO (2019-2020) American Academy of Opthalmology Basic and Clinical Course 2019-2020,
Keywords Section 13 Retina and Vitreous. San Fransisco: American Academy of Opthalmology.
Retinal vein occlusion, branch retinal vein occlusion, anti VEGF 2.Flaxel, C., Adelman, R., Bailey, S., Fawzi, A., Lim, J., Vemulakonda, G. and Ying, G., 2020.
Retinal Vein Occlusions Preferred Practice Pattern®. Ophthalmology, 127(2), pp.P288-P320.